Potential of molecular classification to guide fertility-sparing management among young patients with endometrial cancer.

Abstract excerpt

The traditional histological classification system for endometrial carcinoma falls short in addressing the disease's molecular heterogeneity, prompting the need for alternative stratification methods. Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has emerged as a clinically efficient tool to categorize endometrial cancers according to mismatch repair deficiency, POLE exonuclease domain...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to DNA Mismatch Repair
• Share to Endometrial Neoplasms
• Share to Mutation